Having lost his mother to the disease, singer, songwriter Gavin DeGraw knows firsthand how devastating pancreatic cancer is for patients and their families. Gavin is turning his grief into action by helping the Lustgarten Foundation raise awareness by encouraging people to get involved with the Foundation.
“My mother didn’t make it and unfortunately right now that’s a common story. But it doesn’t have to be the story permanently,” DeGraw said. “By funding research, the Lustgarten Foundation is going to change the course of this disease. I encourage everyone to get involved in some way – join a walk or make a donation.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213753-lustgarten-foundation-pancreatic-cancer-awareness/
Subaru of America, Inc. (SOA) has reported record sales of 513,693 vehicles for the 2014 calendar year. This is an increase of 21 percent over the previous record of 424,683 vehicles, which was set in 2013. This sixth consecutive record also represents the largest ever single–year increase in volume for the brand.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7074156-subaru-reports-record-sales-2014/
When a child is diagnosed with cancer, their family is presented with treatment options – often a combination of surgery, radiation and chemotherapy. Radiation and chemotherapy have been used to treat kids’ cancers for more than 50 years and often come with long-term late effects including secondary cancers, heart damage and cognitive issues. Often a child’s best chance at survival is a clinical trial which offers them the newest treatment options available.
In recognition of Childhood Cancer Awareness Month, the St. Baldrick’s Foundation will highlight the critical need to fund lifesaving research and share stories of kids affected by cancer – like Micah, who is alive today because there was a clinical trial available.
To view the multimedia release go to:
https://www.multivu.com/players/English/8284352-st-baldricks-foundation-conquer-childhood-cancers/
Nespresso has revealed a humorous behind-the-scenes video showing new leading man Jack Black receiving guidance from the ever smooth George Clooney as they filmed the latest TV commercial entitled Epiphany.
The advert explores the concept of ‘What Else?’, provoking viewers to consider the unique Nespresso qualities that are incomparable. ‘What Else?’ encapsulates all of the elements that create the ultimate coffee experience - everything from the unique approach to sustainable coffee, unparalleled coffee quality through to the unsurpassed coffee expertise, stylish boutiques, innovative services and more.
Filmed in Lake Como, Italy, the advert shows George Clooney pouring himself a cup of Nespresso coffee. Just as the coffee is ready, it is taken by Jack Black who attempts to win a female’s affections by trying to use George’s infamous ‘What Else?’ phrase. Oblivious, Jack gets the phrase wrong and George steps in to educate him. Later, Jack experiences a moment of epiphany as the meaning of ‘What Else?’ dawns on him.
George Clooney commented on set: “What can I say about Jack, it was a tall order but he did quite the job - after a bit of coaching of course. All joking aside, it was such a fun shoot and Jack was a pleasure to work with.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7686751-nespresso-jack-black-george-clooney/
The National Inventors Hall of Fame and the United States Patent and Trademark Office (USPTO) will host the Greatest Celebration of American Innovation May 4-5. The two-day event will include the Induction of 16 innovation trailblazers into the Hall of Fame and the unveiling of the expanded National Inventors Hall of Fame Museum.
Mo Rocca, Emmy award-winning CBS Sunday Morning correspondent and Host of The Henry Ford’s Innovation Nation, will give the first official museum tour and serve as Master of Ceremonies for the 44th Annual National Inventors Hall of Fame Induction Ceremony. Participants will have the opportunity to be historians and visionaries as both events focus on honoring the past and inspiring the future.
To view the multimedia release go to:
http://www.multivu.com/players/English/7667851-national-inventors-hall-of-fame/
Flownex SE has increased the ability of engineers to accurately model their fluid–thermal with the release of version of Flownex 2014 on June 19th, 2014. The program is known for its in ease of use, breadth of capability, and depth of functionality. With enhancements in turbomachinery modeling, support for 3D networks, GIS data import, heat transfer and a myriad of additional new features impacting efficiency, integration, and automation, this release expands the industries that can take advantage of it, and will help current users model their systems more accurately with greater ease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7271351-top-ten-new-thermal-fluid-modeling-capabilities-in-flownex-2014-software/
NOAA’s Joint Polar Satellite System-1 (JPSS-1) is encapsulated inside the fairing (nose cone) of a United Launch Alliance Delta II launch vehicle ready for lift off from Space Launch Complex-2W at Vandenberg Air Force Base, California, on November 14, 2017 at 1:47 a.m., PST. JPSS-1 is a collaborative effort between NOAA and NASA.
“The JPSS-1 bus is based on our Ball Configurable Platform 2000, a proven, agile spacecraft, which has 50 years of on-orbit operations and is designed for cost-effective, remote sensing applications,” said Alex Chernushin, JPSS-1 Program Manager, Ball Aerospace. “JPSS-1 is the twelfth spacecraft built on this core architecture, including the Suomi National Polar-orbiting Partnership (Suomi NPP) spacecraft launched in 2011.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7987651-ball-aerospace-joint-polar-satellite-system-jpss-1-launch/
Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
With Memorial Day Weekend and the unofficial start of the summer driving season fast approaching, The Goodyear Tire & Rubber Company surprised unsuspecting motorists here today. NASCAR Sprint Cup Series Champion Kevin Harvick, along with his pit crew, appeared at Concord Mills Mall and performed free tread depth checks on consumers’ tires.
With National Tire Safety Week set for May 29 through June 4, Harvick and Goodyear collaborated to raise awareness on the importance of proper tire maintenance. As always, consumers can head to any of Goodyear’s Tire & Service Network locations to receive free tire checks.
To view the multimedia release go to:
http://www.multivu.com/players/English/7833451-goodyear-tire-check/
Quinny and Maxi-Cosi, premier European brands of Dorel Juvenile, a segment of Dorel Industries (TSX: DII.B, DII.A), and the world's largest juvenile products manufacturer in its categories, today announced its most luxurious collection yet, launching globally, from renowned designer, stylist and editor Rachel Zoe. Rachel Zoe x Quinny and Maxi-Cosi merges the brands’ design-forward, high quality and industry leading safety with Zoe’s unparalleled, award-winning fashion sensibility.
“We’re proud to collaborate with a designer of Rachel Zoe’s caliber,” said Dan Pennacchio, General Manager of Premium Brands at Dorel Juvenile USA. “Our partnership with Rachel once again asserts our expertise in providing style-conscious parents with the latest in designer baby gear. Her insights into the worlds of design and motherhood are captured in the collection’s chic, yet classic and functional aesthetic.”
With nearly two decades of experience in design and fashion, Zoe has become a household name embodying sophisticated, timeless style and Hollywood glamour. From designing her eponymous collection, and authoring two New York Times bestselling books, to acting as Editor-in-Chief of digital style destination The Zoe Report, and most recently returning to TV with Lifetime’s “Fashionably Late with Rachel Zoe,” her influence continues to grow. A mom to two young sons, Zoe’s recent, highly-acclaimed maternity wear collection for A Pea in the Pod exemplifies her ever-expanding appeal to women everywhere.
To view the multimedia release go to:
http://www.multivu.com/players/English/7662251-rachel-zoe-quinny-maxi-cosi/
Ringing out, as it has for centuries, the mission bell beckons across the hillsides calling out to the devoted. Here, where lush hillsides meet the Pacific Ocean, we pursue a singular canon—to make great wine. Canon 13 Pinot Noir and Chardonnay from the Santa Lucia Highlands, our answer to the mission bell, launch nationwide in July to on-premise retailers.
“The Santa Lucia Highlands are as unique as the people who settled them,” says Canon 13 winemaker Tom Klassen. “Sitting high on a bench overlooking a fertile valley, the vines grow deep in the alluvial soils that cling to the hillsides. Our fruit is protected by the maritime breezes that bring with them a gentle fog, ensuring the grapes ripen evenly and provide our wines with supple texture and fragrant aromatics found nowhere else.”
Canon 13 is inspired by our geographic birthplace at the Soledad Mission, the 13th mission located along the El Camino Real, the historic 600-mile stretch of road connecting dozens of missions and pueblos beginning in the late 1700s. The steep Santa Lucia Highlands are located along California’s central coast, near the cool waters of Monterey Bay on the flanks of the Santa Lucia Range. The region is graced by warm days, cool nights, rich soil and an evening fog that nurtures the delicate Chardonnay and Pinot Noir grapes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7409459-canon-13-wines-launch/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will be delivered to U.S. health care providers and pharmacies beginning in July and continuing throughout the remainder of the year. Sanofi Pasteur plans to increase its supply to respond to the shifting pediatric public health needs.
Seasonal influenza activity typically occurs between October and May and peaks between December and February. However, influenza activity peaked noticeably late last season occurring in early March 2016.1 Influenza seasons are always unpredictable as new influenza strains emerge and strain activity fluctuates throughout the year, making timely vaccination even more important to help protect against the virus, especially for seniors, young children and infants six months of age and older.
To view the multimedia release go to:
http://www.multivu.com/players/English/7842051-sanofi-pasteur-influenza-vaccine/
